Clinical trials
Active, not recruiting Schizophrenia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 2 |
| Anavex Life Sciences Corp. | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Bristol-Myers Squibb | 1 |
| Massachusetts General Hospital | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| New York State Psychiatric Institute | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Spinogenix | 1 |
| Temple University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 19 |
| Psychotic Disorders | 6 |
| Bipolar Disorder | 2 |
| Mental Disorders | 2 |
| Aging, Premature | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Chorea | 1 |
| Cognitive Dysfunction | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Disease Progression | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.